Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ENDOMETRIAL NEOPLASMS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06787807
What this trial is testing

Proteomic Analysis of Patients Undergoing Bariatric Surgery

Who this might be right for
ObesityColon CancerThyroid Cancer+14 more
Universidade Federal de Pernambuco 103
Testing effectiveness (Phase 2)Study completedNCT03540407
What this trial is testing

Evaluation of Oncoxin-Viusid® in Cervical Cancer and Endometrial Adenocarcinoma.

Who this might be right for
Cervical Carcinoma Stage IICervical Carcinoma Stage IIICervical Carcinoma Stage IV+3 more
Catalysis SL 66
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07743541
What this trial is testing

Study of TUB-040 in Patients With Recurrent or Progressive Uterine Cancer After Chemotherapy and Immune Therapy

Who this might be right for
Uterine Endometrial Cancer
Tubulis GmbH 100
Early research (Phase 1)Looking for participantsNCT06400472
What this trial is testing

Sofe-M in Participants With Selected Advanced Solid Tumors

Who this might be right for
Ovarian NeoplasmsEndometrial NeoplasmsUterine Cervical Neoplasms+4 more
Eli Lilly and Company 575
Not applicableStudy completedNCT00277082
What this trial is testing

Aerosolized Liposomal Camptothecin in Patients With Metastatic or Recurrent Cancer of the Endometrium or the Lung

Who this might be right for
Corpus UteriLung Cancer
University of New Mexico 24
Testing effectiveness (Phase 2)Study completedNCT00301964
What this trial is testing

Bevacizumab in Treating Patients With Recurrent or Persistent Endometrial Cancer

Who this might be right for
Recurrent Endometrial Carcinoma
National Cancer Institute (NCI) 56
Not applicableUnknownNCT05099978
What this trial is testing

Asian Multicenter Prospective Study of ctDNA Sequencing

Who this might be right for
Cervical CancerOvarian Clear Cell CarcinomaNasopharyngeal Carcinoma+3 more
National Cancer Center, Japan 506
Large-scale testing (Phase 3)Study completedNCT00063999
What this trial is testing

Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer

Who this might be right for
Recurrent Uterine Corpus CarcinomaStage IIIA Uterine Corpus Cancer AJCC v7Stage IIIB Uterine Corpus Cancer AJCC v7+3 more
GOG Foundation 1,381
Testing effectiveness (Phase 2)Study completedNCT02899793
What this trial is testing

Pembrolizumab in Ultramutated and Hypermutated Endometrial Cancer

Who this might be right for
Recurrent Endometrial Cancer
Yale University 25
Early research (Phase 1)Ended earlyNCT06264921
What this trial is testing

A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorSolid Tumor, AdultAdvanced Solid Tumor+26 more
NiKang Therapeutics, Inc. 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT04482309
What this trial is testing

T-DXd in Patients With Selected HER2 Expressing Tumors

Who this might be right for
Part 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal CancerPart 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal Cancer
AstraZeneca 477
Testing effectiveness (Phase 2)Study completedNCT00319748
What this trial is testing

Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers

Who this might be right for
Breast CancerOvarian CancerEndometrial Cancer+1 more
Masonic Cancer Center, University of Minnesota 15
Testing effectiveness (Phase 2)Study completedNCT02744898
What this trial is testing

Feasibility Study of Abraxane and Carboplatin in Epithelial Neoplasms of the Uterus

Who this might be right for
Endometrial Cancer
NYU Langone Health 23
Not applicableUnknownNCT04489706
What this trial is testing

Arsenic Trioxide in Recurrent and Metastatic Ovarian Cancer and Endometrial Cancer With P53 Mutation

Who this might be right for
Ovarian CancerEndometrial Cancer
Ruijin Hospital 20
Early research (Phase 1)WithdrawnNCT05655598
What this trial is testing

TAS-116 Plus Palbociclib in Breast and Rb-null Cancer

Who this might be right for
Advanced Breast CancerTreatment-Refractory Solid TumorsRetinoblastoma Deficiency+4 more
Brown University
Not applicableUnknownNCT03570866
What this trial is testing

PET/CT in the Management of Patients With Early Stage Endometrial Cancer

Who this might be right for
Endometrium Cancer
Università degli Studi dell'Insubria 40
Testing effectiveness (Phase 2)Study completedNCT00107445
What this trial is testing

EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial Cancer

Who this might be right for
Primary Peritoneal Cavity CancerStage I Endometrial CarcinomaStage I Ovarian Epithelial Cancer+13 more
National Cancer Institute (NCI) 60
Not applicableActive Not RecruitingNCT07074795
What this trial is testing

Use of Nitrous Oxide During Office Hysteroscopy

Who this might be right for
Abnormal Uterine BleedingPostmenopausal BleedingEndometrial Polyps+3 more
Maaynei Hayesha Medical Center 400
Testing effectiveness (Phase 2)WithdrawnNCT03836157
What this trial is testing

Mirvetuximab Soravtansine (IMGN853) and Bevacizumab in Patients With Endometrial Cancer

Who this might be right for
Endometrial CancerEndometrial AdenocarcinomaEndometrial Serous Adenocarcinoma+1 more
University of Oklahoma
Testing effectiveness (Phase 2)Looking for participantsNCT05231122
What this trial is testing

Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer

Who this might be right for
Ovarian Clear Cell AdenocarcinomaPlatinum-Sensitive Ovarian CarcinomaRecurrent Endometrial Serous Adenocarcinoma+12 more
Roswell Park Cancer Institute 80
Next Page